BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14984889)

  • 1. Schizophrenia research participants' responses to protocol safeguards: recruitment, consent, and debriefing.
    Roberts LW; Warner TD; Anderson CT; Smithpeter MV; Rogers MK
    Schizophr Res; 2004 Apr; 67(2-3):283-91. PubMed ID: 14984889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation.
    Roberts LW; Warner TD; Brody JL
    Am J Psychiatry; 2000 Jan; 157(1):67-74. PubMed ID: 10618015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and psychiatrist ratings of hypothetical schizophrenia research protocols: assessment of harm potential and factors influencing participation decisions.
    Roberts LW; Warner TD; Brody JL; Roberts B; Lauriello J; Lyketsos C
    Am J Psychiatry; 2002 Apr; 159(4):573-84. PubMed ID: 11925295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of ethical safeguards on research participation: comparison of perspectives of people with schizophrenia and psychiatrists.
    Roberts LW; Hammond KA; Warner TD; Lewis R
    Am J Psychiatry; 2004 Dec; 161(12):2309-11. PubMed ID: 15569905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capacity to provide informed consent for participation in schizophrenia and HIV research.
    Moser DJ; Schultz SK; Arndt S; Benjamin ML; Fleming FW; Brems CS; Paulsen JS; Appelbaum PS; Andreasen NC
    Am J Psychiatry; 2002 Jul; 159(7):1201-7. PubMed ID: 12091200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informed consent: assessment of comprehension.
    Wirshing DA; Wirshing WC; Marder SR; Liberman RP; Mintz J
    Am J Psychiatry; 1998 Nov; 155(11):1508-11. PubMed ID: 9812110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthy individuals' perspectives on clinical research protocols and influences on enrollment decisions.
    Roberts LW; Kim JP
    AJOB Empir Bioeth; 2017; 8(2):89-98. PubMed ID: 28949845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Older adults' attitudes toward enrollment of non-competent subjects participating in Alzheimer's research.
    Karlawish J; Rubright J; Casarett D; Cary M; Ten Have T; Sankar P
    Am J Psychiatry; 2009 Feb; 166(2):182-8. PubMed ID: 18923066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does informed consent given by healthy individuals when enrolling in clinical research feel less voluntary than for ill individuals?
    Roberts L; Kim JP
    J Psychiatr Res; 2018 Aug; 103():33-37. PubMed ID: 29772484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed consent in medication-free schizophrenia research.
    Moser DJ; Reese RL; Schultz SK; Benjamin ML; Arndt S; Fleming FW; Andreasen NC
    Am J Psychiatry; 2005 Jun; 162(6):1209-11. PubMed ID: 15930073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do psychiatrists understand research-related experiences, attitudes, and motivations of schizophrenia study participants?
    Warner TD; Roberts LW; Nguyen K
    Compr Psychiatry; 2003; 44(3):227-33. PubMed ID: 12764711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competence to consent to research among long-stay inpatients with chronic schizophrenia.
    Kovnick JA; Appelbaum PS; Hoge SK; Leadbetter RA
    Psychiatr Serv; 2003 Sep; 54(9):1247-52. PubMed ID: 12954941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do people at risk for Alzheimer disease think about surrogate consent for research?
    Kim SY; Kim HM; McCallum C; Tariot PN
    Neurology; 2005 Nov; 65(9):1395-401. PubMed ID: 16275826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
    Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
    Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attunement and alignment of people with schizophrenia and their preferred alternative decision-makers: An exploratory pilot study comparing treatment and research decisions.
    Roberts LW; Kim JP
    J Psychiatr Res; 2015 Dec; 71():70-7. PubMed ID: 26453915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Views of US researchers about informed consent in international collaborative research.
    Dawson L; Kass NE
    Soc Sci Med; 2005 Sep; 61(6):1211-22. PubMed ID: 15970232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decisional capacity for informed consent in schizophrenia research.
    Carpenter WT; Gold JM; Lahti AC; Queern CA; Conley RR; Bartko JJ; Kovnick J; Appelbaum PS
    Arch Gen Psychiatry; 2000 Jun; 57(6):533-8. PubMed ID: 10839330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inverse relationship between perceived harm and participation willingness in schizophrenia research protocols.
    Roberts LW; Hammond KG; Hoop J
    Am J Psychiatry; 2006 Nov; 163(11):2002-4. PubMed ID: 17074954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical parameters of challenge studies inducing psychosis with ketamine.
    Tishler CL; Gordon LB
    Ethics Behav; 1999; 9(3):211-7. PubMed ID: 11657272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new brief instrument for assessing decisional capacity for clinical research.
    Jeste DV; Palmer BW; Appelbaum PS; Golshan S; Glorioso D; Dunn LB; Kim K; Meeks T; Kraemer HC
    Arch Gen Psychiatry; 2007 Aug; 64(8):966-74. PubMed ID: 17679641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.